[Federal Register: June 1, 2004 (Volume 69, Number 105)]
[Notices]               
[Page 30930-30931]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01jn04-98]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Health Promotion and Disease Prevention Research 
Centers, Special Interest Projects Cooperative Supplements, Program 
Announcement Number 04003

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Health Promotion and Disease 
Prevention Research Centers, Special Interest Projects Cooperative 
Supplements, Program Announcement Number 04003.
    Times and Dates: 8:30 a.m.-8:55 a.m., June 23, 2004 (Open); 9 
a.m.-5 p.m., June 23, 2004 (Closed); 9 a.m.-12 p.m. June 23, 2004 
(Closed).
    Place: Sheraton Colony Square Hotel, 188 14th Street, NE., 
Atlanta, GA 30361, Telephone 404.892.2004.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in Section 552b(c) (4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement Number 04003.

FOR FURTHER INFORMATION CONTACT: Michael N. Waller, Deputy Director,

[[Page 30931]]

National Center for Chronic Disease Prevention and Health Promotion, 
CDC, 4770 Buford Highway, NE., MS-K 45, Atlanta, GA 30341, Telephone 
770.488.5269.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: May 20, 2004.
Joseph E. Salter,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 04-12221 Filed 5-28-04; 8:45 am]

BILLING CODE 4163-18-M